METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) — FDA Approval ANDA211309 (SAPTALIS PHARMS)
METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) — FDA Approval ANDA211309 (SAPTALIS PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: METFORMIN HYDROCHLORIDE; Active ingredients: METFORMIN HYDROCHLORIDE; Application number: ANDA211309.
| Brand name | METFORMIN HYDROCHLORIDE |
|---|---|
| Active ingredients | METFORMIN HYDROCHLORIDE |
| Application number | ANDA211309 |
| Sponsor | SAPTALIS PHARMS |
| Dosage form | SOLUTION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20200303 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →